摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid

中文名称
——
中文别名
——
英文名称
(Z)-2-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
英文别名
[(5Z)-5-(4-chlorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid;2-[(5Z)-5-[(4-chlorophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
(Z)-2-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid化学式
CAS
——
化学式
C12H8ClNO3S2
mdl
——
分子量
313.785
InChiKey
PYYMQCFPFUEAOF-UITAMQMPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    115
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    4-氨基-1-苄基哌啶(Z)-2-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 乙腈 为溶剂, 反应 25.0h, 以43%的产率得到2-((Z)-5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(1-benzylpiperidin-4-yl)acetamide
    参考文献:
    名称:
    Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors
    摘要:
    A series of 5-benzylidenerhodanine-3-acetamides bearing morpholino-, 4-arylpiperazinyl-, or 4-benzylpiperidinyl-moieties were synthesized and their inhibitory activities against acetylcholinesterase (AChE) were evaluated. Alteration of amide part and substitution on the benzylidene moiety resulted in change of anti-AChE activity. The most active compound was the 1-benzylpiperidinyl derivative containing 4-(dimethylamino) benzylidene scaffold. Notably, the intermediate compounds, namely 5-arylidene-rhodanine-3-acetic acids (3), showed mild inhibitory activity against 15-lipoxygenase (15-LOX), while the final compound 4 showed no activity against 15-LOX.
    DOI:
    10.3109/14756366.2014.940935
  • 作为产物:
    描述:
    3-羧甲基绕丹宁4-氯苯甲醛三乙胺硫酸盐 作用下, 以 neat (no solvent) 为溶剂, 反应 0.33h, 以93%的产率得到(Z)-2-(5-(4-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
    参考文献:
    名称:
    [Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity
    摘要:
    我们描述了一种高效、更安全的合成5-芳亚甲基-罗丹宁衍生物的方法,该方法采用布朗斯特酸性离子液体[Et3NH][HSO4]作为催化剂,产率极佳。该方案提供了成本效益高、环境友好、无溶剂的条件以及催化剂的回收再利用。合成的5-芳亚甲基-罗丹宁衍生物通过1H NMR、13C NMR和HRMS光谱数据进行了表征。合成了一系列5-芳亚甲基-罗丹宁衍生物3a–h、4a–h,并评估了它们对休眠的结核分枝杆菌H37Ra和牛分枝杆菌BCG株的体外抗结核活性。此外,化合物3a、3b、3e、3f、3g、3h和4f显示出良好的抗结核活性,并使用改良的MTT assay评估了对MCF-7、A549和HCT116细胞系的抗增殖活性,发现它们无细胞毒性。化合物3a–h和4f进一步筛选了它们对四种细菌株的抗菌活性,以评估它们对结核分枝杆菌的选择性。此外,所有测试化合物的计算机辅助ADME预测遵循口服活性药物的标准,因此,这些化合物可能具有作为口服药物开发的良好潜力。
    DOI:
    10.1007/s11164-016-2484-0
点击查看最新优质反应信息

文献信息

  • [Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity
    作者:Dnyaneshwar D. Subhedar、Mubarak H. Shaikh、Laxman Nawale、Amar Yeware、Dhiman Sarkar、Bapurao B. Shingate
    DOI:10.1007/s11164-016-2484-0
    日期:2016.8
    We have described a highly efficient, safer protocol for the synthesis of 5-arylidene-rhodanine conjugates catalyzed by Bronsted acidic ionic liquid [Et3NH][HSO4] in excellent yields. The protocol offers cost-effective, environmentally benign, solvent-free conditions and recycle–reuse of the catalyst. The synthesized 5-arylidene-rhodanine conjugates were characterized on the basis of 1H NMR, 13C NMR and HRMS spectral data. A series of 5-arylidene-rhodanine derivatives 3a–h, 4a–h were synthesized and evaluated for their in vitro antitubercular activity against dormant Mycobacterium tuberculosis H37Ra and M. bovis BCG strains. Moreover, compounds 3a, 3b, 3e, 3f, 3g, 3h and 4f exhibited good antitubercular activity and were also evaluated for anti-proliferative activity against MCF-7, A549 and HCT116 cell lines using modified MTT assay and found to be noncytotoxic. Compounds 3a–h and 4f were further screened for their antibacterial activity against four bacteria strains to assess their selectivity towards M. tuberculosis. Furthermore, in silico ADME prediction of all the tested compounds followed the criteria for orally active drug and, therefore, these compounds may have a good potential for eventual development as oral agents.
    我们描述了一种高效、更安全的合成5-芳亚甲基-罗丹宁衍生物的方法,该方法采用布朗斯特酸性离子液体[Et3NH][HSO4]作为催化剂,产率极佳。该方案提供了成本效益高、环境友好、无溶剂的条件以及催化剂的回收再利用。合成的5-芳亚甲基-罗丹宁衍生物通过1H NMR、13C NMR和HRMS光谱数据进行了表征。合成了一系列5-芳亚甲基-罗丹宁衍生物3a–h、4a–h,并评估了它们对休眠的结核分枝杆菌H37Ra和牛分枝杆菌BCG株的体外抗结核活性。此外,化合物3a、3b、3e、3f、3g、3h和4f显示出良好的抗结核活性,并使用改良的MTT assay评估了对MCF-7、A549和HCT116细胞系的抗增殖活性,发现它们无细胞毒性。化合物3a–h和4f进一步筛选了它们对四种细菌株的抗菌活性,以评估它们对结核分枝杆菌的选择性。此外,所有测试化合物的计算机辅助ADME预测遵循口服活性药物的标准,因此,这些化合物可能具有作为口服药物开发的良好潜力。
  • Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors
    作者:Yang Xiang、Cheng Chen、Wen-Ming Wang、Li-Wei Xu、Ke-Wu Yang、Peter Oelschlaeger、Yuan He
    DOI:10.1021/acsmedchemlett.7b00548
    日期:2018.4.12
    A series of rhodanines was constructed, their Z-configuration was confirmed by small molecule X-ray crystal structures, and their activity against metallo-β-lactamases (MβLs) was measured. The obtained 26 molecules and a thioenolate specifically inhibited the MβL L1 with an IC50 range of 0.02–1.7 μM, and compounds 2h–m exhibited broad-spectrum inhibition of the MβLs NDM-1, VIM-2, ImiS, and L1 with
    构造了一系列的罗丹宁,它们的Z-构型通过小分子X射线晶体结构得以证实,并测量了它们对金属-β-内酰胺酶(MβLs)的活性。获得的26个分子和硫代烯酸酯专门抑制MβLL1,IC 50范围为0.02–1.7μM,化合物2h – m表现出广谱抑制MβLsNDM-1,VIM-2,ImiS和L1的IC 50个值<16μM。所有抑制剂均增强了头孢唑林对表达L1的大肠杆菌细胞的抗菌作用,导致MIC降低了2-8倍。对接研究表明2l的硝基(NDM-1,CphA和L1)或羧基(VIM-2)配位一个或两个Zn(II)离子,而抑制剂的N-苯基增强了它与MβLs的疏水相互作用。这些研究表明,二芳基取代的罗丹酮是设计未来MβLs广谱抑制剂的良好支架。
  • Ultrasound accelerated solvent-free condensation reaction of rhodanines and carbonyls using Amberlyst 26 as a green and efficient base catalyst
    作者:Duc-Thuan Nguyen、Ngoc-Khoi Pham、Xuan-Triet Nguyen、Thi Xuan Thi Luu、Quynh-Nhi Nguyen Luong
    DOI:10.1080/17415993.2023.2173008
    日期:——
    The solvent-free condensation reaction of various aliphatic aldehydes, cycloalkanones, and benzaldehydes with rhodanines catalyzed by Amberlyst 26 has been reported. The catalyst's efficiency, simple work-up, simple recycling procedure, and high catalyst recyclability without any considerable change of yields several times were found to be interesting. Furthermore, the drastic acceleration of ultrasound
    已报道了 Amberlyst 26 催化的各种脂肪醛、环烷酮和苯甲醛与绕丹宁的无溶剂缩合反应。人们发现该催化剂的效率、简单的后处理、简单的回收程序以及高催化剂可回收性而收率多次没有任何显着变化,这些都是令人感兴趣的。此外,超声波照射的急剧加速被认为对于在短时间内以中等至良好的产率有效地形成亚烷基罗丹宁、环亚烷基罗丹宁和亚芳基罗丹宁。
  • Efficient Synthesis of Rhodanine-Based Amides via Passerini Reaction using Tetramethylguanidine-Functionalized Silica Nanoparticles as Reusable Catalyst
    作者:Robabeh Baharfar、Razieh Azimi、Sheida Barzegar、Mojtaba Mohseni
    DOI:10.5935/0103-5053.20150108
    日期:——
    Novel rhodanine-based amide derivatives were prepared in good yields via Passerini reaction of rhodanine-N-acetic acid with aromatic aldehydes and tert-butyl isocyanide in the presence of tetramethylguanidine immobilized on silica nanoparticles (TMG-SiO2 NPs) as a heterogeneous base catalyst. The synthesized compounds were evaluated for their antibacterial effects against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus subtilis.
  • Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient
    申请人:ONO PHARMACEUTICAL CO., LTD.
    公开号:EP0047109B1
    公开(公告)日:1985-01-02
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物